{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:01:13Z","timestamp":1792522873622,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.psym.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T02:14:33Z","timestamp":1527819273000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature"],"prefix":"10.1016","volume":"60","author":[{"given":"Julie","family":"Rivi\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roos C.","family":"van der Mast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Van Den Eede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0001","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ageing\/afl005","article-title":"Occurrence and outcome of delirium in medical in-patients: a systematic literature review","volume":"35","author":"Siddiqi","year":"2006","journal-title":"Age Ageing"},{"issue":"11","key":"10.1016\/j.psym.2018.05.011_bib0002","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1345\/aph.1H241","article-title":"Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients","volume":"40","author":"Lacasse","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.psym.2018.05.011_bib0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4088\/JCP.v68n0102","article-title":"Antipsychotics in the treatment of delirium: a systematic review","volume":"68","author":"Seitz","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.psym.2018.05.011_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005594.pub2","article-title":"Antipsychotics for delirium","author":"Lonergan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.psym.2018.05.011_bib0005","article-title":"National clinical guideline center: DELIRIUM","year":"2010","journal-title":"Diagn Prev Manag"},{"issue":"12","key":"10.1016\/j.psym.2018.05.011_bib0006","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jagp.2012.09.008","article-title":"O'Regan N: what do we really know about the treatment of delirium with antipsychotics? Ten key issues for delirium pharmacotherapy","volume":"21","author":"Meagher","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"issue":"42","key":"10.1016\/j.psym.2018.05.011_bib0007","first-page":"188","article-title":"Olanzapine and haloperidol for senile delirium: a randomized controlled observation","volume":"10","author":"Hu","year":"2006","journal-title":"Chin J Clin Rehabil"},{"issue":"9920","key":"10.1016\/j.psym.2018.05.011_bib0008","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(13)60688-1","article-title":"Delirium in elderly people","volume":"383","author":"Inouye","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.psym.2018.05.011_bib0009","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0033-3182(10)70723-4","article-title":"Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial","volume":"51","author":"Larsen","year":"2010","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.psym.2018.05.011_bib0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","article-title":"Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit","volume":"41","author":"Barr","year":"2013","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.psym.2018.05.011_bib0011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamainternmed.2016.7491","article-title":"Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial","volume":"177","author":"Agar","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.psym.2018.05.011_bib0012","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpsychores.2010.05.006","article-title":"A randomized controlled trial of quetiapine versus placebo in the treatment of delirium","volume":"69","author":"Tahir","year":"2010","journal-title":"J Psychosom Res"},{"issue":"2","key":"10.1016\/j.psym.2018.05.011_bib0013","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/CCM.0b013e3181b9e302","article-title":"Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study","volume":"38","author":"Devlin","year":"2010","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.psym.2018.05.011_bib0014","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/CCM.0b013e3181c58715","article-title":"Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial","volume":"38","author":"Girard","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.psym.2018.05.011_bib0015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/DDDT.S45575","article-title":"Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial","volume":"7","author":"Maneeton","year":"2013","journal-title":"Drug Des Dev Ther"},{"issue":"3","key":"10.1016\/j.psym.2018.05.011_bib0016","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5498\/wjp.v6.i3.365","article-title":"Comparative effectiveness of quetiapine and haloperidol in delirium: a single blind randomized controlled study","volume":"6","author":"Grover","year":"2016","journal-title":"World J Psychiatry"},{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0017","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0033-3182(04)70170-X","article-title":"A double-blind trial of risperidone and haloperidol for the treatment of delirium","volume":"45","author":"Han","year":"2004","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.psym.2018.05.011_bib0018","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00134-003-2117-0","article-title":"Olanzapine vs haloperidol: treating delirium in a critical care setting","volume":"30","author":"Skrobik","year":"2004","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0019","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpsychores.2011.01.019","article-title":"Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium","volume":"71","author":"Grover","year":"2011","journal-title":"J Psychosom Res"},{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0020","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/hup.1117","article-title":"Risperidone versus olanzapine for the treatment of delirium","volume":"25","author":"Kim","year":"2010","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"10.1016\/j.psym.2018.05.011_bib0021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0885-3924(96)00316-8","article-title":"The memorial delirium assessment scale","volume":"13","author":"Breitbart","year":"1997","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"10.1016\/j.psym.2018.05.011_bib0022","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s001340100909","article-title":"Intensive care delirium screening checklist: evaluation of a new screening tool","volume":"27","author":"Bergeron","year":"2001","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0023","first-page":"451","article-title":"Comparison of efficacy of haloperidol and olanzapine in the treatment of delirium","volume":"59","author":"Jain","year":"2017","journal-title":"Indian J Psychiatry"},{"issue":"10","key":"10.1016\/j.psym.2018.05.011_bib0024","first-page":"2158","article-title":"An open-label study of quetiapine for delirium","volume":"90","author":"Maneeton","year":"2007","journal-title":"J Med Assoc Thai"},{"issue":"11","key":"10.1016\/j.psym.2018.05.011_bib0025","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4088\/JCP.v64n1106","article-title":"A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium","volume":"64","author":"Sasaki","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psym.2018.05.011_bib0026","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1479-8301.2003.00012.x","article-title":"Clinical experience of quetiapine in 24 elderly patients with delirium","volume":"3","author":"Omura K","year":"2003","journal-title":"Psychogeriatrics"},{"issue":"1","key":"10.1016\/j.psym.2018.05.011_bib0027","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0891988702250533","article-title":"Treatment of delirium in older adults with quetiapine","volume":"16","author":"Kim","year":"2003","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"5","key":"10.1016\/j.psym.2018.05.011_bib0028","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1049909114565019","article-title":"Novel therapeutic strategies for delirium in patients with cancer: a preliminary study","volume":"33","author":"Tanimukai","year":"2016","journal-title":"Am J Hosp Palliat Care"},{"issue":"1","key":"10.1016\/j.psym.2018.05.011_bib0029","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1471-244X-13-240","article-title":"Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium","volume":"13","author":"Yoon","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.psym.2018.05.011_bib0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004850-200511000-00005","article-title":"Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study","volume":"20","author":"Lee","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.psym.2018.05.011_bib0031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1440-1819.2005.01355.x","article-title":"Antipsychotics and dopamine transporter gene polymorphisms in delirium patients","volume":"59","author":"Kim","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0032","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0163-8343(03)00024-0","article-title":"Treatment for delirium with risperidone: results of a prospective open trial with 10 patients","volume":"25","author":"Horikawa","year":"2003","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"10.1016\/j.psym.2018.05.011_bib0033","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4088\/JCP.v65n0310","article-title":"Risperidone in the treatment of patients with delirium","volume":"65","author":"Parellada","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.psym.2018.05.011_bib0034","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1440-1819.2012.02346.x","article-title":"Treatment of delirium with risperidone in cancer patients","volume":"66","author":"Kishi","year":"2012","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"10.1016\/j.psym.2018.05.011_bib0035","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4088\/JCP.v65n0510","article-title":"Risperidone in the treatment of delirium: results from a prospective open-label trial","volume":"65","author":"Mittal","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psym.2018.05.011_bib0036","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1479-8301.2008.00227.x","article-title":"Efficacy of risperidone in the treatment of delirium in elderly patients","volume":"8","author":"Ikezawa","year":"2008","journal-title":"Psychogeriatrics"},{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0037","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1017\/S1478951514001059","article-title":"Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: a comparison of efficacy, safety, and side effects","volume":"13","author":"Boettger","year":"2015","journal-title":"Palliat Support Care"},{"issue":"5","key":"10.1016\/j.psym.2018.05.011_bib0038","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0033-3182(98)71301-5","article-title":"Olanzapine in the treatment of delirium","volume":"39","author":"Sipahimalani","year":"1998","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.psym.2018.05.011_bib0039","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1176\/appi.psy.43.3.175","article-title":"An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients","volume":"43","author":"Breitbart","year":"2002","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.psym.2018.05.011_bib0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1440-1819.2001.00898.x","article-title":"An open pilot trial of olanzapine for delirium in the Korean population","volume":"55","author":"Kim","year":"2001","journal-title":"Psychiatry Clin Neurosci"},{"issue":"6","key":"10.1016\/j.psym.2018.05.011_bib0041","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/00048674.2011.543411","article-title":"Aripiprazole and haloperidol in the treatment of delirium","volume":"45","author":"Boettger","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0042","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1017\/S1478951511000368","article-title":"An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients","volume":"9","author":"Boettger","year":"2011","journal-title":"Palliat Support Care"},{"issue":"7","key":"10.1016\/j.psym.2018.05.011_bib0043","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.eurpsy.2009.05.013","article-title":"Study on the efficacy and tolerability of amisulpride in medical\/surgical inpatients with delirium admitted to a general hospital","volume":"24","author":"Pintor","year":"2009","journal-title":"Eur Psychiatry"},{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0044","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1601-5215.2011.00568.x","article-title":"Paliperidone in the treatment of delirium: results of a prospective open-label pilot trial","volume":"23","author":"Yoon","year":"2011","journal-title":"Acta Neuropsychiatr"},{"issue":"1","key":"10.1016\/j.psym.2018.05.011_bib0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1440-1819.2007.01612.x","article-title":"Perospirone in the treatment of patients with delirium","volume":"61","author":"Takeuchi","year":"2007","journal-title":"Psychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0046","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/jgs.14076","article-title":"Antipsychotic medication for prevention and treatment of delirium in hospitalized adults: a systematic review and meta-analysis","volume":"64","author":"Neufeld","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"9896","key":"10.1016\/j.psym.2018.05.011_bib0047","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.psym.2018.05.011_bib0048","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1017\/S1041610213001415","article-title":"Consensus and variations in opinions on delirium care: a survey of European delirium specialists","volume":"25","author":"Morandi","year":"2013","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.psym.2018.05.011_bib0049","series-title":"Handboek psychofarmacotherapie","author":"Dierick","year":"2012"},{"issue":"8","key":"10.1016\/j.psym.2018.05.011_bib0050","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.161.8.1099","article-title":"Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients","volume":"161","author":"Han","year":"2001","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.psym.2018.05.011_bib0051","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jpsychires.2013.02.012","article-title":"Reliability of Delirium Rating Scale (DRS) and Delirium Rating Scale-Revised-98 (DRS-R98) using variance-based multivariate modelling","volume":"47","author":"Adamis","year":"2013","journal-title":"J Psychiatr Res"},{"issue":"2","key":"10.1016\/j.psym.2018.05.011_bib0052","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1176\/jnp.13.2.229","article-title":"Validation of the Delirium Rating Scale-Revised-98: comparison with the Delirium Rating Scale and the cognitive test for delirium","volume":"13","author":"Trzepacz","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.psym.2018.05.011_bib0053","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/cc11407","article-title":"The Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) and Intensive Care Delirium Screening Checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studies","volume":"16","author":"Gusmao-Flores","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.psym.2018.05.011_bib0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.psym.2018.05.011_bib0055","unstructured":"U.S. National Library of Medicine: ClinicalTrials.gov"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318218302585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318218302585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T22:46:26Z","timestamp":1549925186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318218302585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0033318218302585"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2018.05.011","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Psychosomatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psym.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}